ArticleBritish journal of cancer2026

Correction: Safety and efficacy of lapatinib, binimetinib, and vinorelbine for RAS mutant metastatic colorectal cancer: results of the RASTRIC Phase I/II trial.

Maarten A Huismans et al.PubMed ↗Publisher ↗

No numbers read from the abstract.